10x Genomics, Inc. TXG Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s finished goods?
- 10x Genomics, Inc. (TXG) reported finished goods of $17.41M in Q1 2026.
- How has 10x Genomics, Inc.'s finished goods changed year-over-year?
- 10x Genomics, Inc.'s finished goods increased by 13.9% year-over-year, from $15.29M to $17.41M.
- What is the long-term trend for 10x Genomics, Inc.'s finished goods?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s finished goods has grown at a 16.7% compound annual growth rate (CAGR), from $10.72M to $23.18M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.